Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors.
Sakka S, Kandori S, Kawai K, Kojima T, Nitta S, Chihara I, Nagumo Y, Kawahara T, Mathis BJ, Ishihara M, Shinohara N, Kishida T, Ukimura O, Nishimura K, Kobayashi Y, Nishiyama H. Sakka S, et al. Among authors: kobayashi y. Int J Urol. 2023 May;30(5):456-462. doi: 10.1111/iju.15155. Epub 2023 Feb 6. Int J Urol. 2023. PMID: 36746673
Usefulness of postoperative nadir prostate-specific antigen value by ultrasensitive assay as a predictor of prostate-specific antigen relapse for pathological T3 or positive surgical margins after radical prostatectomy for prostate cancer.
Yoshida T, Matsuzaki K, Kobayashi Y, Takeda K, Nakayama M, Arai Y, Kakimoto K, Nishimura K. Yoshida T, et al. Among authors: kobayashi y. Int Urol Nephrol. 2012 Apr;44(2):479-85. doi: 10.1007/s11255-011-0044-5. Epub 2011 Aug 6. Int Urol Nephrol. 2012. PMID: 21822599
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC.
Tomita Y, Naito S, Sassa N, Takahashi A, Kondo T, Koie T, Obara W, Kobayashi Y, Teishima J, Takahashi M, Matsuyama H, Ueda T, Yamaguchi K, Kishida T, Shiroki R, Saika T, Shinohara N, Oya M, Kanayama HO. Tomita Y, et al. Among authors: kobayashi y. Clin Genitourin Cancer. 2020 Aug;18(4):e374-e385. doi: 10.1016/j.clgc.2020.01.001. Epub 2020 Mar 6. Clin Genitourin Cancer. 2020. PMID: 32466961 Free article. Clinical Trial.
Low-dose rituximab induction therapy is effective in immunological high-risk renal transplantation without increasing cytomegalovirus infection.
Yoshinaga K, Araki M, Wada K, Maruyama Y, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Kobayashi Y, Takeuchi H, Tanabe K, Kitagawa M, Morinaga H, Uchida HA, Kitamura S, Sugiyama H, Wada J, Watanabe M, Watanabe T, Nasu Y. Yoshinaga K, et al. Among authors: kobayashi y. Int J Urol. 2020 Dec;27(12):1136-1142. doi: 10.1111/iju.14382. Epub 2020 Oct 3. Int J Urol. 2020. PMID: 33012030 Free article.
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.
Kawahara T, Kawai K, Kojima T, Nagumo Y, Sakka S, Kandori S, Negoro H, Mathis BJ, Maruo K, Miura K, Sakamoto N, Shinohara N, Yamashita S, Yonemori K, Kishida T, Ukimura O, Nishimura K, Kobayashi Y, Nishiyama H. Kawahara T, et al. Among authors: kobayashi y. Int J Urol. 2022 Jul;29(7):741-747. doi: 10.1111/iju.14885. Epub 2022 Apr 23. Int J Urol. 2022. PMID: 35462438 Free PMC article. Clinical Trial.
10,284 results
You have reached the last available page of results. Please see the User Guide for more information.